
Roche has received approval from the European Commission for a new tablet formulation of Evrysdi (risdiplam), marking the first and …
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?

